Current trends in the immunotherapy of metastatic and recurrent squamous cell carcinoma of the head and neck
The immune system plays a key role in the development and progression of head and neck squamous cell carcinoma. Understanding the dysregulation and blockage of the immune system of malignant tumors in this location can improve treatment outcomes. A special group is made up of patients who have a wid...
Main Authors: | Yu. V. Kostalanova, K. A. Ganina, A. A. Makhonin, A. G. Gabrielyan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-11-01
|
Series: | Opuholi Golovy i Šei |
Subjects: | |
Online Access: | https://ogsh.abvpress.ru/jour/article/view/559 |
Similar Items
-
Overcoming Resistance to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinomas
by: Lucas V. dos Santos, et al.
Published: (2021-03-01) -
Research progress on programmed death receptor 1/ ligand 1 inhibitor in immunotherapy of head and neck squamous cell carcinoma
by: ZENG Fei, et al.
Published: (2021-10-01) -
Assays for predicting and monitoring responses to lung cancer immunotherapy
by: Cristina Teixidó, et al.
Published: (2015-06-01) -
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics
by: Margarita Udall, et al.
Published: (2018-02-01) -
The Sarcoma Immune Landscape: Emerging Challenges, Prognostic Significance and Prospective Impact for Immunotherapy Approaches
by: Anna Koumarianou, et al.
Published: (2021-01-01)